Age-associated effect of kestose on Faecalibacterium prausnitzii and symptoms in the atopic dermatitis infants
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although Faecalibacterium prausnitzii is a major bacterium in the intestine of adults, which is known to have anti-inflammatory effects, the development in infants or the response to prebiotics remains unclear. METHODS: The counts of F. prausnitzii in the feces were examined by real-time polymerase chain reaction (PCR). Fecal samples were obtained from 65 atopic dermatitis (AD) infants who participated in a randomized controlled clinical trial to investigate the therapeutic effect of kestose, the smallest fructooligosaccharide. RESULTS: Although the F. prausnitzii count was undetectable level in most 0- to 1-y-old infants, the count reached a level comparable to that in adults in 2- to 5-y-old infants. The bacterial number increased about 10-fold by oral administration of kestose every day for 12 wk in the younger infants, but not so much in the older infants. This bacterial increase was significantly correlated with an improvement in the AD symptoms in the older infants. CONCLUSION: The F. prausnitzii population in the intestine reaches a level comparable to that in adult at approximately 2 y of age. Kestose efficiently stimulates the growth of this bacterium in the intestine, which might lead to an improvement in AD symptoms in infants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“Some species of Clostridium, a dominant genus of commensal microbes in the gut, are known to induce Treg cells (19,20).”
BackgroundRound, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233 · cited 1×
“Some species of Clostridium, a dominant genus of commensal microbes in the gut, are known to induce Treg cells (19,20).”
BackgroundDevelopmental microbial ecology of the neonatal gastrointestinal tract
Mackie, R. I., Sghir, A., & Gaskins, H. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.1035s · Cited by 1,360 · cited 1×
“prausnitzii in the hosts ranging from early to late infancy who suffered from AD, using Bifidobacterium as a control because this genus is well known to be predominant at early infancy and remains a major component of the intestinal microbiota during all infancy (12).”
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275 · cited 1×
“prausnitzii is reported to be depleted in AD (10) as well as inflammatory bowel diseases (11).”
BackgroundRamirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G., & Louis, P. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508019880 · Cited by 822 · cited 1×
“Moreover, in a clinical study to examine the effect of inulin in the gut microbiota (17), no increase was found in the B.”
BackgroundInfluence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
Tsuda, A., Suda, W., Morita, H., Takanashi, K., Takagi, A., Koga, Y., & Hattori, M. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.20 · Cited by 164 · cited 2×
“Faecalibacterium prausnitzii is one of the abundant bacteria in the intestinal microbiota in adults, accounting for 5–15% of the total bacterial population (8,9).”
BackgroundMethodSelf-citation
Cited by
Laursen, M. F., Sakanaka, M., von Burg, N., Mörbe, U., Andersen, D., Moll, J. M., Pekmez, C. T., Rivollier, A., Michaelsen, K. F., Mølgaard, C., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00970-4 · Cited by 581
The role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 357
Demirci, M., Tokman, H. B., Uysal, H. K., Demiryas, S., Karakullukcu, A., Saribas, S., Cokugras, H., & Kocazeybek, B. S. (2019) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2018.12.009 · Cited by 150
Functional and nutraceutical properties of fructo-oligosaccharides derivatives: A review
Rahim, M. A., Saeed, F., Khalid, W., Hussain, M., & Anjum, F. M. (2021) · International Journal of Food Properties · doi:10.1080/10942912.2021.1986520 · Cited by 108
Prebiotics in atopic dermatitis prevention and management
Lee, Y. H., Verma, N. K., & Thanabalu, T. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104352 · Cited by 19
Metadata
- Authors
- Koga, Y., Tokunaga, S., Nagano, J., Sato, F., Konishi, K., Tochio, T., Murakami, Y., Masumoto, N., Tezuka, J.-I., Sudo, N., Kubo, C., & Shibata, R.
- Venue
- Pediatric Research
- Published
- 2016-08-16
- Volume
- 80
- Issue
- 6
- Pages
- 844-851
- ISSN
- 0031-3998 (ISSN-L)
- 1530-0447
- OpenAlex
- W2507750815
- Cited by
- 66
- References
- 6
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.